Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model
- 1 March 2016
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 225, 240-251
Abstract
No abstract availableKeywords
Funding Information
- King Abdulaziz City for Science and Technology (12-MED2535)
This publication has 34 references indexed in Scilit:
- Breast cancer stem cells: Obstacles to therapyCancer Letters, 2013
- Salinomycin as a Drug for Targeting Human Cancer Stem CellsJournal of Biomedicine and Biotechnology, 2012
- Mammosphere cells from high-passage MCF7 cell line show variable loss of tumorigenicity and radioresistanceCancer Letters, 2012
- The application of carbon nanotubes in target drug delivery systems for cancer therapiesDiscover Nano, 2011
- Circumventing Tumor Resistance to Chemotherapy by Nanotechnology2009
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput ScreeningCell, 2009
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and AngiogenesisJournal of Clinical Oncology, 2008
- Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesisNature Reviews Cancer, 2007
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003